Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Ortho Clinical Diagnostics plc Ordinary Shares stock

Own Ortho Clinical Diagnostics plc Ordinary Shares stock in just a few minutes.

Ortho Clinical Diagnostics plc Ordinary Shares is a diagnostics & research business based in the US. Ortho Clinical Diagnostics plc Ordinary Shares shares (OCDX) are listed on the NASDAQ and all prices are listed in US Dollars. Ortho Clinical Diagnostics plc Ordinary Shares employs 4,500 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Ortho Clinical Diagnostics plc Ordinary Shares

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OCDX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Ortho Clinical Diagnostics plc Ordinary Shares share price

Use our graph to track the performance of OCDX stocks over time.

Ortho Clinical Diagnostics plc Ordinary Shares shares at a glance

Information last updated 2021-03-24.
52-week range$15.14 - $20.43
50-day moving average $17.49
200-day moving average $17.42
Wall St. target price$24.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Ortho Clinical Diagnostics plc Ordinary Shares shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Ortho Clinical Diagnostics plc Ordinary Shares stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Ortho Clinical Diagnostics plc Ordinary Shares under- or over-valued?

Valuing Ortho Clinical Diagnostics plc Ordinary Shares stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ortho Clinical Diagnostics plc Ordinary Shares's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ortho Clinical Diagnostics plc Ordinary Shares's EBITDA

Ortho Clinical Diagnostics plc Ordinary Shares's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $390.5 million.

The EBITDA is a measure of a Ortho Clinical Diagnostics plc Ordinary Shares's overall financial performance and is widely used to measure a its profitability.

To put Ortho Clinical Diagnostics plc Ordinary Shares's EBITDA into context you can compare it against that of similar companies.

Ortho Clinical Diagnostics plc Ordinary Shares financials

Revenue TTM $1.8 billion
Operating margin TTM 6.23%
Gross profit TTM $880.4 million
Return on assets TTM 1.97%
Return on equity TTM 0%
Profit margin -12%
Book value N/A
Market capitalisation $4.5 billion

TTM: trailing 12 months

Shorting Ortho Clinical Diagnostics plc Ordinary Shares shares

There are currently 717,864 Ortho Clinical Diagnostics plc Ordinary Shares shares held short by investors – that's known as Ortho Clinical Diagnostics plc Ordinary Shares's "short interest". This figure is 24.7% up from 575,610 last month.

There are a few different ways that this level of interest in shorting Ortho Clinical Diagnostics plc Ordinary Shares shares can be evaluated.

Ortho Clinical Diagnostics plc Ordinary Shares's "short interest ratio" (SIR)

Ortho Clinical Diagnostics plc Ordinary Shares's "short interest ratio" (SIR) is the quantity of Ortho Clinical Diagnostics plc Ordinary Shares shares currently shorted divided by the average quantity of Ortho Clinical Diagnostics plc Ordinary Shares shares traded daily (recently around 3.4 million). Ortho Clinical Diagnostics plc Ordinary Shares's SIR currently stands at 0.21. In other words for every 100,000 Ortho Clinical Diagnostics plc Ordinary Shares shares traded daily on the market, roughly 210 shares are currently held short.

To gain some more context, you can compare Ortho Clinical Diagnostics plc Ordinary Shares's short interest ratio against those of similar companies.

However Ortho Clinical Diagnostics plc Ordinary Shares's short interest can also be evaluated against the total number of Ortho Clinical Diagnostics plc Ordinary Shares shares, or, against the total number of tradable Ortho Clinical Diagnostics plc Ordinary Shares shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ortho Clinical Diagnostics plc Ordinary Shares's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Ortho Clinical Diagnostics plc Ordinary Shares shares in existence, roughly 0 shares are currently held short) or 0.0064% of the tradable shares (for every 100,000 tradable Ortho Clinical Diagnostics plc Ordinary Shares shares, roughly 6 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ortho Clinical Diagnostics plc Ordinary Shares.

Find out more about how you can short Ortho Clinical Diagnostics plc Ordinary Shares stock.

Ortho Clinical Diagnostics plc Ordinary Shares share dividends

We're not expecting Ortho Clinical Diagnostics plc Ordinary Shares to pay a dividend over the next 12 months.

Ortho Clinical Diagnostics plc Ordinary Shares overview

Ortho Clinical Diagnostics Holdings plc engages in the vitro diagnostics business worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company also engages in contract manufacturing activities; and provides orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. The company was founded in 1939 and is headquartered in Raritan, New Jersey. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site